Validation of a Novel Device for Screening Patients With Symptoms of Obstructive Sleep Apnea
Launched by BELUN TECHNOLOGY COMPANY LIMITED · Oct 9, 2019
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject must have the ability to understand and provide written informed consent.
- • Subject is 18 to 90 years of age.
- • Subject must be willing and able to comply with study procedures and duration.
- • Male or female of any race.
- Exclusion Criteria:
- • Subject requires oxygen therapy or noninvasive ventilation.
- • Subject has a current diagnosis of chronic obstructive pulmonary disorder (COPD), neuromuscular disease, periodic limb movement, or narcolepsy.
- • Compromised circulation, injury, or physical malformation of fingers, toes, hands, ears or forehead/skull or other sensor sites which would limit the ability to test sites needed for the study. (Note: Certain malformations may still allow subjects to participate if the condition is noted and would not affect the particular sites utilized.)
- • Subject is on medication known to interfere with heart rate, such as beta blockers, digoxin, or calcium receptor agonists.
- • Subjects with severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors, ECG electrodes, respiration monitor electrodes or other medical sensors (self-reported).
- • Unwillingness or inability to remove colored nail polish from test digits.
- • Other known health condition, which should be considered.
About Belun Technology Company Limited
Belun Technology Company Limited is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative medical technologies and solutions. With a focus on developing cutting-edge diagnostic tools and therapeutic devices, Belun leverages its expertise in research and development to enhance patient outcomes and streamline clinical processes. Committed to rigorous scientific standards and ethical practices, the company collaborates with healthcare professionals and institutions to conduct high-quality clinical trials that contribute to the advancement of medical knowledge and improve the quality of care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Denver, Colorado, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials